TY - JOUR AU - Adejolu, M. AU - Huo, L. AU - Rohren, E. PY - 2012 DA - 2012// TI - False-positive lesions mimicking breast cancer on FDG PET and PET/CT JO - AJR Am J Roentgenol VL - 198 UR - https://doi.org/10.2214/AJR.11.7130 DO - 10.2214/AJR.11.7130 ID - Adejolu2012 ER - TY - JOUR AU - Aide, N. AU - Lasnon, C. AU - Veit-Haibach, P. PY - 2017 DA - 2017// TI - EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies JO - Eur J Nucl Med Mol Imaging VL - 44 UR - https://doi.org/10.1007/s00259-017-3740-2 DO - 10.1007/s00259-017-3740-2 ID - Aide2017 ER - TY - STD TI - American Cancer Society. Cancer Facts and Figures 2017. Atlanta, GA: American Cancer Society, 2017 Available at: https://wwwcancerorg/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2017/cancer-facts-and-figures-2017pdf Assessed: 6, Sept 2017 UR - https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2017/cancer-facts-and-figures-2017.pdf ID - ref3 ER - TY - JOUR AU - Arpino, G. AU - Clark, G. M. AU - Mohsin, S. PY - 2002 DA - 2002// TI - Adenoid cystic carcinoma of the breasr JO - Cancer VL - 94 UR - https://doi.org/10.1002/cncr.10455 DO - 10.1002/cncr.10455 ID - Arpino2002 ER - TY - JOUR AU - Avril, N. AU - Rosi, C. A. AU - Schelling, M. PY - 2000 DA - 2000// TI - Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations JO - J Clin Oncol VL - 18 UR - https://doi.org/10.1200/JCO.2000.18.20.3495 DO - 10.1200/JCO.2000.18.20.3495 ID - Avril2000 ER - TY - STD TI - Barthel H, Wilson H, Collingridge DR et al (2004) In vivo evaluation of [18F] fluoroetanidazole as a new marker for imaging tumor hypoxia with positron emission tomography. Br J Cancer 90(11):2232–2242 ID - ref6 ER - TY - JOUR AU - Basu, S. AU - Chen, W. AU - Tchou, J. PY - 2008 DA - 2008// TI - Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization JO - Cancer VL - 112 UR - https://doi.org/10.1002/cncr.23226 DO - 10.1002/cncr.23226 ID - Basu2008 ER - TY - JOUR AU - Baum, R. P. AU - Prasad, V. AU - Müller, D. PY - 2010 DA - 2010// TI - Molecular imaging of HER2-expressing malignant tumors in breast cancer patients using synthetic 111In- or 68Ga-labeled affibody molecules JO - J Nucl Med VL - 51 UR - https://doi.org/10.2967/jnumed.109.073239 DO - 10.2967/jnumed.109.073239 ID - Baum2010 ER - TY - JOUR AU - Bauwens, M. AU - De Saint-Hubert, M. AU - Devos, E. PY - 2011 DA - 2011// TI - Site-specific 68Ga-labeled Annexin A5 as a PET imaging agent for apoptosis JO - Nucl Med Biol VL - 38 UR - https://doi.org/10.1016/j.nucmedbio.2010.09.008 DO - 10.1016/j.nucmedbio.2010.09.008 ID - Bauwens2011 ER - TY - JOUR AU - Beer, A. J. AU - Niemeyer, M. AU - Carlsen, J. PY - 2008 DA - 2008// TI - Patterns of alphavbeta3 expression in primary and metastatic human breast cancer as shown by 18F-Galacto-RGD PET JO - J Nucl Med VL - 49 UR - https://doi.org/10.2967/jnumed.107.045526 DO - 10.2967/jnumed.107.045526 ID - Beer2008 ER - TY - JOUR AU - Beylergil, V. AU - Morris, P. G. AU - Smith-Jones, P. M. PY - 2013 DA - 2013// TI - Pilot study of 68Ga-DOTA-F(ab')2-trastuzumab in patients with breast cancer JO - Nucl Med Commun VL - 34 ID - Beylergil2013 ER - TY - JOUR AU - Bitencourt, A. G. V. AU - Lima, E. N. P. AU - Chojniak, R. PY - 2014 DA - 2014// TI - Correlation between PET/CT results and histological and immunohistochemical findings in breast carcinomas JO - Radiol Bras VL - 47 UR - https://doi.org/10.1590/S0100-39842014000200006 DO - 10.1590/S0100-39842014000200006 ID - Bitencourt2014 ER - TY - JOUR AU - Blankenberg, F. G. PY - 2009 DA - 2009// TI - Imaging the molecular signatures of apoptosis and injury with radiolabeled annexin V JO - Proc Am Thorac Soc VL - 6 UR - https://doi.org/10.1513/pats.200901-001AW DO - 10.1513/pats.200901-001AW ID - Blankenberg2009 ER - TY - JOUR AU - Buck, A. K. AU - Schirrmeister, H. AU - Mattfeldt, T. PY - 2004 DA - 2004// TI - Biological characterisation of breast cancer by means of PET JO - Eur J Nucl Med Mol Imaging VL - 31 UR - https://doi.org/10.1007/s00259-004-1529-6 DO - 10.1007/s00259-004-1529-6 ID - Buck2004 ER - TY - JOUR AU - Caldarella, C. AU - Treglia, G. AU - Giordano, A. PY - 2014 DA - 2014// TI - Diagnostic performance of dedicated positron emission mammography using fluorine-18-fluorodeoxyglucose in women with suspicious breast lesions: a meta-analysis JO - Clin Breast Cancer VL - 14 UR - https://doi.org/10.1016/j.clbc.2013.12.004 DO - 10.1016/j.clbc.2013.12.004 ID - Caldarella2014 ER - TY - JOUR AU - Cardoso, F. AU - van’t Veer, L. J. AU - Bogaerts, J. PY - 2016 DA - 2016// TI - 70-gene signature as an aid to treatment decisions in early-stage breast cancer JO - N Engl J Med VL - 375 UR - https://doi.org/10.1056/NEJMoa1602253 DO - 10.1056/NEJMoa1602253 ID - Cardoso2016 ER - TY - JOUR AU - Cervino, A. R. AU - Burei, M. AU - Mansi, L. PY - 2013 DA - 2013// TI - Molecular pathways and molecular imaging in breast cancer: an update JO - Nucl Med Biol VL - 40 UR - https://doi.org/10.1016/j.nucmedbio.2013.03.002 DO - 10.1016/j.nucmedbio.2013.03.002 ID - Cervino2013 ER - TY - JOUR AU - Chan, S. R. AU - Fowler, A. M. AU - Allen, J. A. PY - 2015 DA - 2015// TI - Longitudinal noninvasive imaging of progesterone receptor as a predictive biomarker of tumor responsiveness to estrogen deprivation therapy JO - Clin Cancer Res VL - 21 UR - https://doi.org/10.1158/1078-0432.CCR-14-1715 DO - 10.1158/1078-0432.CCR-14-1715 ID - Chan2015 ER - TY - JOUR AU - Chen, H. AU - Niu, G. AU - Wu, H. PY - 2016 DA - 2016// TI - Clinical application of radiolabeled RGD peptides for PET imaging of integrin αvβ3 JO - Theranostics VL - 6 UR - https://doi.org/10.7150/thno.13242 DO - 10.7150/thno.13242 ID - Chen2016 ER - TY - JOUR AU - Choi, B. B. AU - Kim, S. H. AU - Kang, B. J. PY - 2012 DA - 2012// TI - Diffusion-weighted imaging and FDG PET/CT: predicting the prognoses with apparent diffusion coefficient values and maximum standardized uptake values in patients with invasive ductal carcinoma JO - World J Surg Oncol VL - 10 UR - https://doi.org/10.1186/1477-7819-10-126 DO - 10.1186/1477-7819-10-126 ID - Choi2012 ER - TY - JOUR AU - Cochet, A. AU - Pigeonnat, S. AU - Khoury, B. PY - 2012 DA - 2012// TI - Evaluation of breast tumor blood flow with dynamic first-pass 18F-FDG PET/CT: comparison with angiogenesis markers and prognostic factors JO - J Nucl Med VL - 53 UR - https://doi.org/10.2967/jnumed.111.096834 DO - 10.2967/jnumed.111.096834 ID - Cochet2012 ER - TY - JOUR AU - Cokmert, S. AU - Tanriverdi, O. AU - Karapolat, I. PY - 2016 DA - 2016// TI - The maximum standardized uptake value of metastatic site in 18 F-FDG PET/CT predicts molecular subtypes and survival in metastatic breast cancer: an Izmir oncology group study JO - JBUON VL - 21 ID - Cokmert2016 ER - TY - JOUR AU - Crippa, F. AU - Agresti, R. AU - Sandri, M. PY - 2015 DA - 2015// TI - 18F-FLT PET/CT as an imaging tool for early prediction of pathological response in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy: a pilot study JO - Eur J Nucl Med Mol Imaging VL - 42 UR - https://doi.org/10.1007/s00259-015-2995-8 DO - 10.1007/s00259-015-2995-8 ID - Crippa2015 ER - TY - JOUR AU - Crippa, F. AU - Seregni, E. AU - Agresti, R. PY - 1998 DA - 1998// TI - Association between [18F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observation JO - Eur J Nucl Med VL - 25 UR - https://doi.org/10.1007/s002590050319 DO - 10.1007/s002590050319 ID - Crippa1998 ER - TY - STD TI - Dalm SU, Verzijlbergen JF, De Jong M (2017) Review: Receptor Targeted Nuclear Imaging of Breast Cancer. Int J Mol Sci:18(2) ID - ref25 ER - TY - JOUR AU - David Groheux Hatt, M. AU - Hindié, E. PY - 2013 DA - 2013// TI - Estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast tumors: early prediction of chemosensitivity with (18) F-fluorodeoxyglucose positron emission tomography/computed tomography during neoadjuvant chemotherapy JO - Cancer VL - 119 UR - https://doi.org/10.1002/cncr.28020 DO - 10.1002/cncr.28020 ID - David Groheux Hatt2013 ER - TY - JOUR AU - de Ajambuja, E. AU - Cardoso, F. AU - de Castro, G. PY - 2007 DA - 2007// TI - Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12155 patients JO - Br J Cancer VL - 96 UR - https://doi.org/10.1038/sj.bjc.6603756 DO - 10.1038/sj.bjc.6603756 ID - de Ajambuja2007 ER - TY - JOUR AU - DeGrado, T. R. AU - Baldwin, S. W. AU - Wang, S. PY - 2001 DA - 2001// TI - Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers JO - J Nucl Med VL - 42 ID - DeGrado2001 ER - TY - JOUR AU - Dehdashti, F. AU - Laforest, R. AU - Gao, F. PY - 2012 DA - 2012// TI - Assessment of progesterone receptors in breast carcinoma by PET with 21-18F-fluoro-16α,17α-[(R)-(1′-α-furylmethylidene)dioxy]-19-norpregn-4-ene-3,20-dione JO - J Nucl Med VL - 53 UR - https://doi.org/10.2967/jnumed.111.098319 DO - 10.2967/jnumed.111.098319 ID - Dehdashti2012 ER - TY - JOUR AU - Dehdashti, F. AU - Mortimer, J. E. AU - Siegel, B. A. PY - 1995 DA - 1995// TI - Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays JO - J Nucl Med VL - 36 ID - Dehdashti1995 ER - TY - JOUR AU - Diab, S. G. AU - Clark, G. M. AU - Osborne, C. K. PY - 1999 DA - 1999// TI - Tumor characteristics and clinical outcome of tubular and mucinous breast carcinomas JO - JCO VL - 17 UR - https://doi.org/10.1200/JCO.1999.17.5.1442 DO - 10.1200/JCO.1999.17.5.1442 ID - Diab1999 ER - TY - JOUR AU - Ekmekcioglu, O. AU - Aliyev, A. PY - 2013 DA - 2013// TI - Yilmaz et al. correlation of 18F-fluorodeoxyglucose uptake with histopathological prognostic factors in breast carcinoma JO - Nucl Med Commun VL - 34 UR - https://doi.org/10.1097/MNM.0b013e3283658369 DO - 10.1097/MNM.0b013e3283658369 ID - Ekmekcioglu2013 ER - TY - JOUR AU - Elston, E. W. AU - Ellis, I. O. PY - 1993 DA - 1993// TI - Method for grading breast cancer JO - J Clin Pathol VL - 46 UR - https://doi.org/10.1136/jcp.46.2.189-b DO - 10.1136/jcp.46.2.189-b ID - Elston1993 ER - TY - JOUR AU - Eo, J. S. AU - Chun, I. K. AU - Paeng, J. C. PY - 2012 DA - 2012// TI - Imaging sensitivity of dedicated positron emission mammography in relation to tumor size JO - Breast VL - 21 UR - https://doi.org/10.1016/j.breast.2011.08.002 DO - 10.1016/j.breast.2011.08.002 ID - Eo2012 ER - TY - JOUR AU - Escalona, S. AU - Blasco, J. A. AU - Reza, M. M. PY - 2010 DA - 2010// TI - A systematic review of FDG-PET in breast cancer JO - Med Oncol VL - 27 UR - https://doi.org/10.1007/s12032-009-9182-3 DO - 10.1007/s12032-009-9182-3 ID - Escalona2010 ER - TY - JOUR AU - Gebhart, G. AU - Gámez, C. AU - Holmes, E. PY - 2013 DA - 2013// TI - 18F-FDG PET/CT for early prediction of response to neoadjuvant Lapatinib, Trastuzumab, and their combination in HER2-positive breast Cancer: results from neo-ALTTO JO - J Nucl Med VL - 54 UR - https://doi.org/10.2967/jnumed.112.119271 DO - 10.2967/jnumed.112.119271 ID - Gebhart2013 ER - TY - JOUR AU - Gil-Rendo, A. AU - Martizez-Regueira, F. AU - Zornoza, G. PY - 2009 DA - 2009// TI - Association between [18F]fluorodeoxyglucose uptake and prognostic parameters in breast cancer JO - Br JSurg VL - 96 UR - https://doi.org/10.1002/bjs.6459 DO - 10.1002/bjs.6459 ID - Gil-Rendo2009 ER - TY - JOUR AU - Goldstein, R. AU - Sosabowski, J. AU - Vigor, K. PY - 2013 DA - 2013// TI - Developments in single photon emission computed tomography and PET-based HER2 molecular imaging for breast cancer JO - Expert Rev Anticancer Ther VL - 13 UR - https://doi.org/10.1586/era.13.11 DO - 10.1586/era.13.11 ID - Goldstein2013 ER - TY - STD TI - Gradishar WJ, Anderson BO, Balassanian R et al. NCCN Clinical Practice Guidelines in Oncology. Breast Cancer. Version 2. 2017. Available at: https://www.nccn.org/professionals/physician_gls/f_guidelines.asp#site. Assessed: 12, July 2017 UR - https://www.nccn.org/professionals/physician_gls/f_guidelines.asp#site ID - ref39 ER - TY - JOUR AU - Groheux, D. AU - Giacchetti, S. AU - Hatt, Μ. PY - 2013 DA - 2013// TI - HER2-overexpressing breast cancer: FDG uptake after two cycles of chemotherapy predicts the outcome of neoadjuvant treatment JO - Br J Cancer VL - 109 UR - https://doi.org/10.1038/bjc.2013.469 DO - 10.1038/bjc.2013.469 ID - Groheux2013 ER - TY - JOUR AU - Henry, K. E. AU - Dilling, T. R. AU - Abdel-Atti, D. PY - 2018 DA - 2018// TI - Noninvasive 89Zr-transferrin PET shows improved tumor targeting compared with 18F-FDG PET in MYC-overxpressing human triple negative breast cancer JO - J Nucl Med VL - 59 UR - https://doi.org/10.2967/jnumed.117.192286 DO - 10.2967/jnumed.117.192286 ID - Henry2018 ER - TY - JOUR AU - Henry, K. E. AU - Ulaner, G. A. AU - Lewis, J. S. PY - 2017 DA - 2017// TI - Human epidermal growth factor receptor 2-targeted PET/single- photon emission computed tomography imaging of breast Cancer: noninvasive measurement of a biomarker integral to tumor treatment and prognosis JO - PET Clin VL - 12 UR - https://doi.org/10.1016/j.cpet.2017.02.001 DO - 10.1016/j.cpet.2017.02.001 ID - Henry2017 ER - TY - JOUR AU - Heudel, P. AU - Cimarelli, S. AU - Montella, A. PY - 2010 DA - 2010// TI - Value of PET-FDG in primary breast cancer based on histopathological and immunohistochemical prognostic factors JO - Int Clin Oncol VL - 15 UR - https://doi.org/10.1007/s10147-010-0120-3 DO - 10.1007/s10147-010-0120-3 ID - Heudel2010 ER - TY - JOUR AU - Higuchi, T. AU - Nishimukai, A. AU - Ozawa, H. PY - 2016 DA - 2016// TI - Prognostic significance of preoperative 18F-FDG PET/CT for breast cancer subtypes JO - Breast VL - 30 UR - https://doi.org/10.1016/j.breast.2016.08.003 DO - 10.1016/j.breast.2016.08.003 ID - Higuchi2016 ER - TY - JOUR AU - Hodi, Z. AU - Chakrabarti, J. AU - Lee, A. H. PY - 2007 DA - 2007// TI - The reliability of assessment of oestrogen receptor expression on needle core biopsy specimens of invasive carcinomas of the breast JO - J Clin Pathol VL - 60 UR - https://doi.org/10.1136/jcp.2006.036665 DO - 10.1136/jcp.2006.036665 ID - Hodi2007 ER - TY - JOUR AU - Hu, S. AU - Kiesewetter, D. O. AU - Zhu, L. PY - 2012 DA - 2012// TI - Longitudinal PET imaging of doxorubicin-induced cell death with 18F-Annexin V JO - Mol Imaging Biol VL - 14 UR - https://doi.org/10.1007/s11307-012-0551-5 DO - 10.1007/s11307-012-0551-5 ID - Hu2012 ER - TY - JOUR AU - Iakovou, I. P. AU - Giannoula, E. PY - 2014 DA - 2014// TI - Nuclear medicine in diagnosis of breast cancer JO - Hell J Nucl Med VL - 17 ID - Iakovou2014 ER - TY - JOUR AU - J Avril, N. AU - Menzel, M. AU - Dose, J. PY - 2001 DA - 2001// TI - Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis JO - Nucl Med VL - 42 ID - J Avril2001 ER - TY - JOUR AU - Jung, N. Y. AU - Kim, S. H. AU - Choi, B. B. PY - 2015 DA - 2015// TI - Associations between the standardized uptake value of (18)F-FDG PET/CT and the prognostic factors of invasive lobular carcinoma: in comparison with invasive ductal carcinoma JO - World J Surg Oncol VL - 13 UR - https://doi.org/10.1186/s12957-015-0522-9 DO - 10.1186/s12957-015-0522-9 ID - Jung2015 ER - TY - JOUR AU - Kadoya, T. AU - Aogi, K. AU - Kiyoto, S. PY - 2013 DA - 2013// TI - Role of maximum standardized uptake value in fluorodeoxyglucose positron emission tomography/computed tomography predicts malignancy grade and prognosis of operable breast cancer: a multi-institute study JO - Breast Cancer Res Treat VL - 141 UR - https://doi.org/10.1007/s10549-013-2687-7 DO - 10.1007/s10549-013-2687-7 ID - Kadoya2013 ER - TY - JOUR AU - Karantanis, D. AU - Allen-Auerbach, M. AU - Czernin, J. PY - 2012 DA - 2012// TI - Sources and resources for oncologists to help answer the question: is PET/CT appropriate for my patient? JO - Hell J Nucl Med VL - 15 ID - Karantanis2012 ER - TY - JOUR AU - Kazmierczak, P. M. AU - Todica, A. AU - Gildehaus, F. J. PY - 2016 DA - 2016// TI - 68Ga-TRAP-(RGD)3 hybrid imaging for the in vivo monitoring of αvß3-integrin expression as biomarker of anti-Angiogenic therapy effects in experimental breast Cancer JO - PLoS One VL - 11 UR - https://doi.org/10.1371/journal.pone.0168248 DO - 10.1371/journal.pone.0168248 ID - Kazmierczak2016 ER - TY - JOUR AU - Kenny, L. PY - 2016 DA - 2016// TI - The use of novel PET tracers to image breast Cancer biologic processes such as proliferation, DNA damage and repair, and angiogenesis JO - J Nucl Med VL - 57 UR - https://doi.org/10.2967/jnumed.115.157958 DO - 10.2967/jnumed.115.157958 ID - Kenny2016 ER - TY - JOUR AU - Kenny, L. M. AU - Contractor, K. B. AU - Hinz, R. PY - 2010 DA - 2010// TI - Reproducibility of [11C]choline-positron emission tomography and effect of trastuzumab JO - Clin Cancer Res VL - 16 UR - https://doi.org/10.1158/1078-0432.CCR-10-0468 DO - 10.1158/1078-0432.CCR-10-0468 ID - Kenny2010 ER - TY - JOUR AU - Kitajima, K. AU - Fukushima, K. AU - Miyoshi, Y. PY - 2015 DA - 2015// TI - Association between 18F-FDG uptake and molecular subtype of breast cancer JO - Eur J Nucl Med Mol Imaging VL - 42 UR - https://doi.org/10.1007/s00259-015-3070-1 DO - 10.1007/s00259-015-3070-1 ID - Kitajima2015 ER - TY - JOUR AU - Koo, H. R. AU - Park, J. S. AU - Kang, K. W. PY - 2014 DA - 2014// TI - 18F-FDG uptake in breast cancer correlates with immunohistochemically defined subtypes JO - Eur Radiol VL - 24 UR - https://doi.org/10.1007/s00330-013-3037-1 DO - 10.1007/s00330-013-3037-1 ID - Koo2014 ER - TY - JOUR AU - Koolen, B. B. AU - Vidal-Sicart, S. AU - Benlloch Baviera, J. M. AU - Valdés Olmos, R. A. PY - 2014 DA - 2014// TI - Evaluating heterogeneity of primary tumor (18)F-FDG uptake in breast cancer with a dedicated breast PET (MAMMI): a feasibility study based on correlation with PET/CT JO - Nucl Med Commun VL - 35 UR - https://doi.org/10.1097/MNM.0000000000000072 DO - 10.1097/MNM.0000000000000072 ID - Koolen2014 ER - TY - JOUR AU - Koolen, B. B. AU - Vogel, W. V. AU - Vrancken Peeters, M. J. PY - 2012 DA - 2012// TI - Molecular imaging in breast Cancer: from whole-body PET/CT to dedicated breast PET JO - J Oncol VL - 2012 UR - https://doi.org/10.1155/2012/438647 DO - 10.1155/2012/438647 ID - Koolen2012 ER - TY - JOUR AU - Koolen, B. B. AU - Vrancken Peeters, M. J. PY - 2012 DA - 2012// TI - Association of primary tumour FDG uptake with clinical, histopathological and molecular characteristics in breast cancer patients scheduled for neoadjuvant chemotherapy JO - EurJNuclMedMol Imaging VL - 39 ID - Koolen2012 ER - TY - JOUR AU - Kumar, R. AU - Rani, N. AU - Patel, C. PY - 2009 DA - 2009// TI - False-negative and false-positive results in FDG-PET and PET/CT in breast Cancer JO - PET Clin VL - 4 UR - https://doi.org/10.1016/j.cpet.2009.09.002 DO - 10.1016/j.cpet.2009.09.002 ID - Kumar2009 ER - TY - JOUR AU - Lavayssière, R. AU - Cabée, A. E. AU - Filmont, J. E. PY - 2009 DA - 2009// TI - Positron emission tomography (PET) and breast cancer in clinical practice JO - Eur J Radiol VL - 69 UR - https://doi.org/10.1016/j.ejrad.2008.07.039 DO - 10.1016/j.ejrad.2008.07.039 ID - Lavayssière2009 ER - TY - JOUR AU - Li, C. I. AU - Uribe, D. J. AU - Daling, J. R. PY - 2005 DA - 2005// TI - Clinical characteristics of different histologic types of breast cancer JO - Br J Cancer VL - 93 UR - https://doi.org/10.1038/sj.bjc.6602787 DO - 10.1038/sj.bjc.6602787 ID - Li2005 ER - TY - JOUR AU - Linden, H. M. AU - Stekhova, S. A. AU - Link, J. M. PY - 2006 DA - 2006// TI - Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2005.04.3810 DO - 10.1200/JCO.2005.04.3810 ID - Linden2006 ER - TY - CHAP AU - Lybum, I. D. AU - Brown, E. F. ED - Michell, J. M. PY - 2010 DA - 2010// TI - Application of positron emission tomography – computerized tomography in breast cancer BT - Contemporary Issues in cancer imaging. Breast Cancer PB - Cambridge University Press CY - New York ID - Lybum2010 ER - TY - JOUR AU - Madar, I. AU - Huang, Y. PY - 2009 DA - 2009// TI - Ravert H, et al detection and quantification of the evolution dynamics of apoptosis using the PET voltage sensor 18F-fluorobenzyl triphenyl phosphonium JO - J Nucl Med VL - 50 UR - https://doi.org/10.2967/jnumed.108.061283 DO - 10.2967/jnumed.108.061283 ID - Madar2009 ER - TY - JOUR AU - Magometschnigg, H. F. AU - Helbich, T. AU - Brader, P. PY - 2014 DA - 2014// TI - Molecular imaging for the characterization of breast tumors JO - Expert Rev Anticancer Theor VL - 14 UR - https://doi.org/10.1586/14737140.2014.885383 DO - 10.1586/14737140.2014.885383 ID - Magometschnigg2014 ER - TY - JOUR AU - Mankoff, D. A. AU - Eary, J. F. AU - Link, J. M. PY - 2007 DA - 2007// TI - Tumor-specific positron emission tomography imaging in patients: [18F] fluorodeoxyglucose and beyond JO - ClinCancerRes VL - 13 ID - Mankoff2007 ER - TY - JOUR AU - Mavi, A. AU - Cermik, T. F. AU - Urhan, M. PY - 2007 DA - 2007// TI - The effects of estrogen, progesterone, and C-erbB-2 receptor states on 18F-FDG uptake of primary breast cancer lesions JO - J Nucl Med VL - 48 UR - https://doi.org/10.2967/jnumed.106.037440 DO - 10.2967/jnumed.106.037440 ID - Mavi2007 ER - TY - JOUR AU - McVeigh, T. P. AU - Hughes, L. M. AU - Miller, N. PY - 2014 DA - 2014// TI - The impact of Oncotype DX testing in breast cancer management and chemotherapy prescribing patterns in a tertiary referral Centre JO - Eur J Cancer VL - 50 UR - https://doi.org/10.1016/j.ejca.2014.08.002 DO - 10.1016/j.ejca.2014.08.002 ID - McVeigh2014 ER - TY - JOUR AU - Mintun, M. A. AU - Welch, M. J. AU - Siegel, B. A. PY - 1988 DA - 1988// TI - Breast cancer: PET imaging of estrogen receptors JO - Radiology VL - 169 UR - https://doi.org/10.1148/radiology.169.1.3262228 DO - 10.1148/radiology.169.1.3262228 ID - Mintun1988 ER - TY - JOUR AU - Miyake, K. K. AU - Nakamoto, Y. AU - Kanao, S. PY - 2014 DA - 2014// TI - Journal Club: diagnostic value of (18)F-FDG PET/CT and MRI in predicting the clinicopathologic subtypes of invasive breast cancer JO - AJR Am J Roentgenol VL - 203 UR - https://doi.org/10.2214/AJR.13.11971 DO - 10.2214/AJR.13.11971 ID - Miyake2014 ER - TY - JOUR AU - Mortimer, J. E. AU - Dehdashti, F. AU - Siegel, B. A. PY - 2001 DA - 2001// TI - Metabolic flare: indicator of hormone responsiveness in advanced breast cancer JO - J Clin Oncol VL - 19 UR - https://doi.org/10.1200/JCO.2001.19.11.2797 DO - 10.1200/JCO.2001.19.11.2797 ID - Mortimer2001 ER - TY - JOUR AU - Niu, G. AU - Chen, X. PY - 2010 DA - 2010// TI - Apoptosis imaging: beyond annexin V JO - J Nucl Med VL - 51 UR - https://doi.org/10.2967/jnumed.110.078584 DO - 10.2967/jnumed.110.078584 ID - Niu2010 ER - TY - JOUR AU - Ogawa, K. AU - Aoki, M. PY - 2014 DA - 2014// TI - Radiolabeled apoptosis imaging agents for early detection of response to therapy JO - Scientific World Journal VL - 2014 UR - https://doi.org/10.1155/2014/732603 DO - 10.1155/2014/732603 ID - Ogawa2014 ER - TY - JOUR AU - Ohara, M. AU - Shigematsu, H. AU - Tsutani, Y. PY - 2013 DA - 2013// TI - Role of FDG-PET/CT in evaluating surgical outcomes of operable breast cancer -- usefulness for malignant grade of triple-negative breast cancer JO - Breast VL - 22 UR - https://doi.org/10.1016/j.breast.2013.05.003 DO - 10.1016/j.breast.2013.05.003 ID - Ohara2013 ER - TY - JOUR AU - Osborne, J. R. AU - Port, E. AU - Gonen, M. PY - 2010 DA - 2010// TI - 18-FDG PET of locally invasive breast Cancer and Association of Estrogen Receptor Status with standardized uptake value: microarray and Immunohistochemical analysis JO - J Nucl Med VL - 51 UR - https://doi.org/10.2967/jnumed.108.060459 DO - 10.2967/jnumed.108.060459 ID - Osborne2010 ER - TY - JOUR AU - Oude Munnink, T. H. AU - Brouwers, A. H. AU - de Vries, E. G. PY - 2014 DA - 2014// TI - Considerations on absence of 68Ga-DOTA-F(ab')2-trastuzumab tracer uptake in HER2-overexpressing tumor lesions JO - Nucl Med Commun VL - 35 UR - https://doi.org/10.1097/MNM.0000000000000123 DO - 10.1097/MNM.0000000000000123 ID - Oude Munnink2014 ER - TY - STD TI - Paquette M, Lavallée É, Phoenix et al (2017) Improved Estrogen Receptor Assessment by PET Using the Novel Radiotracer 4FMFES in ER+ Breast Cancer Patients: an Ongoing Phase II Clinical Trial. J Nucl Med [Epub ahead of print] ID - ref78 ER - TY - JOUR AU - Perou, C. M. AU - Sorlie, T. AU - Eisen, M. B. PY - 2000 DA - 2000// TI - Molecular portraits of human breast tumors JO - Nature VL - 406 UR - https://doi.org/10.1038/35021093 DO - 10.1038/35021093 ID - Perou2000 ER - TY - JOUR AU - Peterson, L. M. AU - Kurland, B. F. AU - Link, J. M. PY - 2011 DA - 2011// TI - Factors influencing the uptake of 18F-fluoroestradiol in patients with estrogen receptor positive breast cancer JO - Nucl Med Biol VL - 38 UR - https://doi.org/10.1016/j.nucmedbio.2011.03.002 DO - 10.1016/j.nucmedbio.2011.03.002 ID - Peterson2011 ER - TY - JOUR AU - Peterson, L. M. AU - Mankoff, D. A. AU - Lawton, T. PY - 2008 DA - 2008// TI - Quantitative imaging of estrogen receptor expression in breast cancer with PET and 18F-fluoroestradiol JO - J Nucl Med VL - 49 UR - https://doi.org/10.2967/jnumed.107.047506 DO - 10.2967/jnumed.107.047506 ID - Peterson2008 ER - TY - JOUR AU - Pinker, K. AU - Bogner, W. AU - Gruber, S. PY - 2011 DA - 2011// TI - Molecular imaging in breast Cancer - potential future aspects JO - Breast Care (Basel) VL - 6 UR - https://doi.org/10.1159/000328275 DO - 10.1159/000328275 ID - Pinker2011 ER - TY - JOUR AU - Rajendran, J. G. PY - 2005 DA - 2005// TI - KrohnKA. Imaging hypoxia and angiogenesis in tumors JO - Radiol Clin N Am VL - 43 UR - https://doi.org/10.1016/j.rcl.2004.08.004 DO - 10.1016/j.rcl.2004.08.004 ID - Rajendran2005 ER - TY - JOUR AU - Rasey, J. S. AU - Koh, W. J. AU - Grierson, J. R. PY - 1989 DA - 1989// TI - Radiolabelled fluoromisonidazole as an imaging agent for tumor hypoxia JO - Int J Radiat Oncol Biol Phys VL - 17 UR - https://doi.org/10.1016/0360-3016(89)90146-6 DO - 10.1016/0360-3016(89)90146-6 ID - Rasey1989 ER - TY - JOUR AU - Ravdin, P. M. AU - Siminoff, L. A. AU - Davis, G. J. PY - 2001 DA - 2001// TI - Compute program to assist in making decisions about adjuvant therapy for women with early breast cancer JO - J Clin Oncol VL - 19 UR - https://doi.org/10.1200/JCO.2001.19.4.980 DO - 10.1200/JCO.2001.19.4.980 ID - Ravdin2001 ER - TY - JOUR AU - Riegger, C. AU - Herrmann, J. AU - Nagarajah, J. PY - 2012 DA - 2012// TI - Whole-body FDG PET/CT is more accurate than conventional imaging for staging primary breast cancer patients JO - Eur J Nucl Med Mol Imaging VL - 39 UR - https://doi.org/10.1007/s00259-012-2077-0 DO - 10.1007/s00259-012-2077-0 ID - Riegger2012 ER - TY - JOUR AU - Sanli, Y. AU - Kuyumcu, S. AU - Ozkan, Z. G. PY - 2012 DA - 2012// TI - Increased FDG uptake in breast cancer is associated with prognostic factors JO - Ann Nucl Med VL - 26 UR - https://doi.org/10.1007/s12149-012-0579-2 DO - 10.1007/s12149-012-0579-2 ID - Sanli2012 ER - TY - JOUR AU - Schillaci, O. PY - 2012 DA - 2012// TI - Use of dual-point fluorodeoxyglucose imaging to enhance sensitivity and specificity JO - Semin Nucl Med VL - 42 UR - https://doi.org/10.1053/j.semnuclmed.2012.02.003 DO - 10.1053/j.semnuclmed.2012.02.003 ID - Schillaci2012 ER - TY - JOUR AU - Shimoda, W. AU - Hayashi, M. AU - Murakami, K. PY - 2007 DA - 2007// TI - The relationship between FDG uptake in PET scans and biological behavior in breast Cancer JO - Breast Cancer VL - 14 UR - https://doi.org/10.2325/jbcs.14.260 DO - 10.2325/jbcs.14.260 ID - Shimoda2007 ER - TY - STD TI - Sobin LH, Gospodarowicz MK, Wittekind CH UICC: TNM classification of malignant tumors, 7th edn. Wiley-Blackwell, Oxford ID - ref90 ER - TY - JOUR AU - Soerjomataram, I. AU - Louwman, M. W. J. AU - Ribot, J. G. PY - 2008 DA - 2008// TI - An overview of prognostic factors for long-term survivors of breast cancer JO - Breast Cancer Res Treat VL - 107 UR - https://doi.org/10.1007/s10549-007-9556-1 DO - 10.1007/s10549-007-9556-1 ID - Soerjomataram2008 ER - TY - JOUR AU - Sörensen, J. AU - Sandberg, D. AU - Sandström, M. PY - 2014 DA - 2014// TI - First-in-human molecular imaging of HER2 expression in breast cancer metastases using the 111In-ABY-025 affibody molecule JO - J Nucl Med VL - 55 UR - https://doi.org/10.2967/jnumed.113.131243 DO - 10.2967/jnumed.113.131243 ID - Sörensen2014 ER - TY - JOUR AU - Soussan, M. AU - Orlhac, F. AU - Boubaya, M. PY - 2014 DA - 2014// TI - Relationship between tumor heterogeneity measured on FDG-PET/CT and pathological prognostic factors in invasive breast Cancer JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0094017 DO - 10.1371/journal.pone.0094017 ID - Soussan2014 ER - TY - JOUR AU - Sun, Y. AU - Yang, Z. AU - Zhang, Y. PY - 2015 DA - 2015// TI - The preliminary study of 16α-[18F]fluoroestradiol PET/CT in assisting the individualized treatment decisions of breast cancer patients JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0116341 DO - 10.1371/journal.pone.0116341 ID - Sun2015 ER - TY - JOUR AU - Tateishi, U. AU - Terauchi, T. AU - Akashi-Tanaka, S. PY - 2012 DA - 2012// TI - Comparative study of the value of dual tracer PET/CT in evaluating breast cancer JO - Cancer Sci VL - 103 UR - https://doi.org/10.1111/j.1349-7006.2012.02348.x DO - 10.1111/j.1349-7006.2012.02348.x ID - Tateishi2012 ER - TY - JOUR AU - Tchou, J. AU - Sonnad, S. S. AU - Bergey, M. R. PY - 2010 DA - 2010// TI - Degree of tumor FDG uptake correlates with proliferation index in triple negative breast cancer JO - Mol Imaging Biol VL - 12 UR - https://doi.org/10.1007/s11307-009-0294-0 DO - 10.1007/s11307-009-0294-0 ID - Tchou2010 ER - TY - JOUR AU - Teixeira, S. C. AU - Rebolleda, J. F. AU - Koolen, B. B. PY - 2016 DA - 2016// TI - Evaluation of a hanging-breast PET system for primary tumor visualization in patients with stage I-III breast Cancer: comparison with standard PET/CT JO - AJR Am J Roentgenol VL - 206 UR - https://doi.org/10.2214/AJR.15.15371 DO - 10.2214/AJR.15.15371 ID - Teixeira2016 ER - TY - JOUR AU - Tolmachev, V. AU - Velikyan, I. AU - Sandström, M. PY - 2010 DA - 2010// TI - A HER2-binding Affibody molecule labelled with 68Ga for PET imaging: direct in vivo comparison with the 111In-labelled analogue JO - Eur J Nucl Med Mol Imaging VL - 37 UR - https://doi.org/10.1007/s00259-009-1367-7 DO - 10.1007/s00259-009-1367-7 ID - Tolmachev2010 ER - TY - JOUR AU - Tural, D. AU - Kivrak Salim, D. AU - Mutlu, H. PY - 2015 DA - 2015// TI - Is there any relation between PET-CT SUVmax value and prognostic factors in locally advanced breast cancer? JO - JBUON VL - 20 ID - Tural2015 ER - TY - JOUR AU - Turner, N. C. AU - Neven, P. AU - Loibl, S. PY - 2017 DA - 2017// TI - Advances in the treatment of advanced oestrogen-receptor-positive breast cancer JO - Lancet VL - 389 UR - https://doi.org/10.1016/S0140-6736(16)32419-9 DO - 10.1016/S0140-6736(16)32419-9 ID - Turner2017 ER - TY - JOUR AU - Ueda, S. AU - Tsuda, H. AU - Asakawa, H. PY - 2008 DA - 2008// TI - Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positronemission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer JO - Jpn J Clin Oncol VL - 38 UR - https://doi.org/10.1093/jjco/hyn019 DO - 10.1093/jjco/hyn019 ID - Ueda2008 ER - TY - JOUR AU - van Kruchten, M. AU - de Vries, E. G. AU - Brown, M. PY - 2013 DA - 2013// TI - PET imaging of oestrogen receptors in patients with breast cancer JO - Lancet Oncol VL - 14 UR - https://doi.org/10.1016/S1470-2045(13)70292-4 DO - 10.1016/S1470-2045(13)70292-4 ID - van Kruchten2013 ER - TY - JOUR AU - Weigelt, B. AU - Geyer, F. C. AU - Reis-Filho, J. S. PY - 2010 DA - 2010// TI - Histological types of breast cancer: how special are they? JO - Mol Oncol VL - 4 UR - https://doi.org/10.1016/j.molonc.2010.04.004 DO - 10.1016/j.molonc.2010.04.004 ID - Weigelt2010 ER - TY - JOUR AU - Wolff, A. C. AU - Hammond, M. E. AU - Hicks, D. G. PY - 2013 DA - 2013// TI - Recommendations for human epidermal growth factor receptor 2 testing in breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/JCO.2013.50.9984 DO - 10.1200/JCO.2013.50.9984 ID - Wolff2013 ER - TY - STD TI - Yeh SHH, Kong FL, Lin MH (2017) Visualization of Apoptosis: Annexin V Imaging. In: Inoue T, Yang D, Huang G (eds) Personalized Pathway-Activated Systems Imaging in Oncology. Springer Nature Singapore Pte Ltd, pp 233–243 ID - ref105 ER - TY - JOUR AU - Zhang, J. AU - Jia, Z. AU - Ragaz, J. PY - 2013 DA - 2013// TI - The maximum standardized uptake value of 18 F-FDG PET scan to determine prognosis of hormone-receptor positive metastatic breast cancer JO - BMC Cancer VL - 13 UR - https://doi.org/10.1186/1471-2407-13-42 DO - 10.1186/1471-2407-13-42 ID - Zhang2013 ER - TY - STD TI - Zijlstra S, Gunawan J, Burchert W (2003) Synthesis and evaluation of a 18F-labelled recombinant annexin-V derivative, for identification and quantification of apoptotic cells with PET. Appl Radiat Isot 58(2):201–207 ID - ref107 ER -